Application 213222
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ICATIBANT ACETATE | ICATIBANT ACETATE | INJECTABLE;SUBCUTANEOUS | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68462-828 | Icatibant | icatibant acetate | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |
| 68462-828 | Icatibant | icatibant acetate | GLENMARK PHARMACEUTICALS INC., USA | ANDA | Current |